News

Posted: 2017-01-30

Dr. Nathan Lack, one of the VPC’s former post-doctoral fellows, has returned to his geographic and academic roots. A Vancouver Coastal Health Research Institute (VCHRI)’s Rising Star in 2011 and a Michael Smith post-doctoral fellow, he has continued to shine across the Atlantic at the exceptionally competitive and highly regarded Koç University School of Medicine in Istanbul, Turkey as an Associate Professor.

Posted: 2016-11-29

Dr. Amina Zoubeidi is the focus of a Nov. 25 article in the Vancouver Coastal Health Research Institute newsletter.  Read the full article here (opens in new window).

MyPOP logo
Posted: 2016-11-23

The VPC's My Precision Oncology Program (MyPOP) is the lead story in the November 22, 2016 issue of Research Insider, the Vancouver Coastal Health Research Institute's newsletter.  The article includes an interview with Dr Alexander Wyatt, a Senior Research Scientist at our Centre.  Read the full article here (opens in new window)

Posted: 2016-11-02

For the third consecutive year, the University of British Columbia and the Vancouver Prostate Centre’s Prostate Cancer Supportive Care Program participated in the 16th annual Pacific Northwest Prostate Cancer Symposium on Saturday September 24, 2016. This year was Vancouver’s turn to host the symposium for patients, their families and health care professionals, in conjunction with the OHSU Knight Cancer Institute and the University of Washington School of Medicine.

Dr. Cox on Breakfast Television
Posted: 2016-11-01

Dr. Michael Cox joined host Dawn Chubai on Breakfast Television this morning, where he was interviewed about prostate cancer and Movember.  Watch the 5-minute segment at Breakfast TV's website here (opens in new window, Flash required).

Posted: 2016-10-30

A study lead by Dr. Zoubeidi with a team from the Vancouver Prostate Centre and collaborators at Weill Cornell Medicine has been published online on October 26, in AACR's journal Cancer Discovery.

Posted: 2016-10-26

OncoGenex Pharmaceuticals Inc. has announced positive survival results from the final analysis of the Apatorsen Phase 2 Borealis-2™ trial in metastatic bladder cancer.  Apatorsen (OGX-427) was discovered at the VPC and outlicensed to OncoGenex.  The full press release is below; click here for the original article on PR Newswire (opens in new window).
 

BGI - PHC - VPC signing
Posted: 2016-10-20

VANCOUVER, BC, Canada and SHENZHEN, China - Five leading health and research organizations in British Columbia and the world’s largest genomics organization, based in China, have formed a global partnership to bring together advanced technologies and individualized therapy for cancer and other diseases.

VPC Terry Fox Run participants at Stanley Park
Posted: 2016-10-13

The Terry Fox Research Institute published a news article outlining the success of the TFRI-funded teams in the 2016 Terry Fox run.  The VPC team raised $40,000 between online and offline pledges, with over $23,000 raised by Dr. Gleave and over $12,000 by Dr. Black.  We would like to thank all donors, volunteers and participants for making this run very successful.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.